Table 2 Antimicrobial resistance of P. aeruginosa isolates (n = 73)
Resistance % (n) | ||||
|---|---|---|---|---|
Antimicrobials | MIC breakpoint (μg/mL) | Higha | Lowb | Total |
Amikacin | ≤16 - ≥64 | 0.0 | 0.0 | 0.0 |
Aztreonam | ≤8 - ≥32 | 15.1 (11) | 26.0 (19) | 41.1 (30) |
Cefepime | ≤8 - ≥32 | 0.0 | 9.6 (7) | 9.6 (7) |
Ceftazidime | ≤8 - ≥32 | 0.0 | 2.7 (2) | 2.7 (2) |
Ciprofloxacin | ≤1 - ≥4 | 15.1 (11) | 0.0 | 15.1 (11) |
Colistin | ≤2 - ≥8 | 0.0 | 0.0 | 0.0 |
Gentamicin | ≤4 - ≥16 | 2.7 (2) | 9.6 (7) | 12.3 (9) |
Imipenem | ≤4 - ≥16 | 1.4 (1) | 0.0 | 1.4 (1) |
Meropenem | ≤2 - ≥8 | 1.4 (1) | 0.0 | 1.4 (1) |
Piperacillin + tazobactam | ≤16/4 - ≥128/4 | 1.4 (1) | 11.0 (8) | 12.3 (9) |
Ticarcillin | ≤64 - ≥128 | 16.4 (12) | 0.0 | 16.4 (12) |
Ticarcillin + clavulanic acid | ≤64/2 - ≥128/2 | 17.8 (13) | 0.0 | 17.8 (13) |
Tobramycin | ≤4 - ≥16 | 1.4 (1) | 0.0 | 1.4 (1) |